Episodes

Wednesday Sep 22, 2021
Wednesday Sep 22, 2021
Dr. Angela Garinis, Assistant Professor at the Oregon Hearing Research Center at Oregon Health & Science University, and Dr. Ahmet Uluer, Director of the Adult Cystic Fibrosis Program at the combined Boston Children’s Hospital and Brigham & Women’s Hospital Adult Cystic Fibrosis Center, discuss the pathogenesis of CF with focus on the microbiome and use of ototoxic treatments; synergistic ototoxic effects (e.g., noise, inflammation, other treatments) and ototoxicity monitoring and management options for CF care centers. They also briefly discuss novel clinical ototherapeutic trials. This presentation was part of CFRI's Virtual 34th National CF Education Conference on August 1, 2021.
CFRI's 34th National CF Education Conference was sponsored by Vertex Pharmaceuticals, Genentech, Gilead Sciences, Chiesi USA, AbbVie, and Ionis Pharmaceuticals.
Comments (0)
To leave or reply to comments, please download free Podbean or
No Comments
To leave or reply to comments,
please download free Podbean App.